Cost of heart failure in Swedish primary healthcare

被引:39
作者
Agvall, B
Borgquist, L
Foldevi, M
Dahlström, U
机构
[1] Fac Hlth Sci, Dept Hlth & Soc, Linkoping, Sweden
[2] Linkoping Univ, Dept Cardiol, Linkoping, Sweden
关键词
family practice; healthcare costs; heart failure;
D O I
10.1080/02813430500197647
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives. To calculate the cost for patients with heart failure (HF) in a primary healthcare setting. Design. Retrospective study of all available patient data during a period of one year. Setting. Two healthcare centers in Linkoping in the southeastern region of Sweden, covering a population of 19 400 inhabitants. Subjects. A total of 115 patients with a diagnosis of HF. Main outcome measures. The healthcare costs for patients with HF and the healthcare utilization concerning hospital days and visits to doctors and nurses in hospital care and primary healthcare. Results. The mean annual cost for a patient with HF was SEK 37 100. There were no significant differences in cost between gender, age, New York Heart Association functional class, and cardiac function. The distribution of cost was 47% for hospital care, 22% for primary healthcare, 18% for medication, 5% for nursing home, and 6% for examinations. Conclusion. Hospital care accounts for the largest cost but the cost in primary healthcare is larger than previously shown. The total annual cost for patients with HF in Sweden is in the range of SEK 5.0-6.7 billion according to this calculation, which is higher than previously known.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 18 条
[1]   Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences [J].
Agvall, B ;
Dahlström, U .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2001, 19 (01) :14-19
[2]  
Alehagen U., 2002, HeartDrug, V2, P211, DOI 10.1159/000067723
[3]   Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden -: Analysis using data from the cardiac insufficiency bisoprolol study II trial [J].
Ekman, M ;
Zethraeus, N ;
Jönsson, B .
PHARMACOECONOMICS, 2001, 19 (09) :901-916
[4]   Cost effectiveness in the treatment of heart failure with Ramipril - A Swedish substudy of the AIRE study [J].
Erhardt, L ;
Ball, S ;
Andersson, F ;
Bergentoft, P ;
Martinez, C .
PHARMACOECONOMICS, 1997, 12 (02) :256-266
[5]   Heart failure clinics: a possible means of improving care [J].
Erhardt, L ;
Cline, C .
HEART, 1998, 80 (05) :428-429
[6]   Change in the prevalence of coronary heart disease among Finnish elderly men and women in the 1990s [J].
Hartikainen, S ;
Ahto, M ;
Löppönen, M ;
Puolijoki, H ;
Laippala, P ;
Ojanlatva, A ;
Kivelä, SL ;
Isoaho, R .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (03) :178-181
[7]   Direct medical costs for patients with type 2 diabetes in Sweden [J].
Henriksson, F ;
Agardh, CD ;
Berne, C ;
Bolinder, J ;
Lönnqvist, F ;
Stenström, P ;
Östenson, CG ;
Jönsson, B .
JOURNAL OF INTERNAL MEDICINE, 2000, 248 (05) :387-396
[8]   Health care costs of heart failure:: results from a randomised study of patient education [J].
Linné, AB ;
Liedholm, H ;
Jendteg, S ;
Israelsson, B .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (03) :291-297
[9]  
Mair FS, 1996, BRIT J GEN PRACT, V46, P77
[10]   Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population [J].
McDonagh, TA ;
Morrison, CE ;
Lawrence, A ;
Ford, I ;
TunstallPedoe, H ;
McMurray, JJV ;
Dargie, HJ .
LANCET, 1997, 350 (9081) :829-833